ADVANCES - Medical Distribution · No reproduction or diffusion without written authorization. PACK...

4
THD ® & Levorag ® are trademarks of THD SpA - All rights reserved IN THE TREATMENT OF ANAL FISSURES ADVANCES IN THE TREATMENT OF ANAL FISSURES ADVANCES Obsidian – Market analysis

Transcript of ADVANCES - Medical Distribution · No reproduction or diffusion without written authorization. PACK...

Page 1: ADVANCES - Medical Distribution · No reproduction or diffusion without written authorization. PACK SIZE: 20 3.5 ml single-dose tubes with built-in applicator. ... ADVANCES. Internal

THD® & Levorag® are trademarks of THD SpA - All rights reserved

IN THE TREATMENT OF

ANAL FISSURES

ADVANCESIN THE TREATMENT OF

ANAL FISSURES

ADVANCES

Obs

idia

n –

Mar

ket a

naly

sis

Page 2: ADVANCES - Medical Distribution · No reproduction or diffusion without written authorization. PACK SIZE: 20 3.5 ml single-dose tubes with built-in applicator. ... ADVANCES. Internal

IF SYMPTOMS PERSIST, OR IF LEFT UNTREATED, IT CAN LEAD TO

FIRST LINE APPROACH TO THE TREATMENT OF ANAL FISSURES

ANAL FISSURESANAL FISSURESAnal Fissures are the SECOND MOST COMMON RECTAL AILMENT after haemorrhoidal disease.

Anal Fissures are a common condition affecting people of all ages, but they are most prevalent among 20 - 40 year olds.

Causes:

PERSISTENT HYPERTONIA of the internal anal sphincter muscle, which can be caused by constipation, pain and stress.

LOCAL ISCHAEMIA.

1

2

IF SYMPTOMS PERSIST, OR IF LEFT UNTREATED, IT CAN LEAD TO:

PAIN: the patient will experience intense and acute pain. This is a common symptom which can affect the anal canal and is most prevalent during and after defecation.

BLEEDING

ALTERED INTESTINAL MOTILITY

According to the data presented in the Annual Report published by the SICCR (Italian Society of Colorectal Surgery) in 2009, its centres managed a total of 5.199 cases of anal fissures, of which 1.924 (37%) underwent surgical treatment.

ACUTE ANAL FISSURE

PAIN

IAS SPASMHIGH RESTING

ANAL PRESSURE

REDUCED ANODERMAL PERFUSION

LOCAL ISCHAEMIA

POOR HEALING

MICROTRAUMA?

FIRST LINE APPROACH TO THE TREATMENT OF ANAL FISSURES

Obs

idia

n –

Mar

ket a

naly

sis

Page 3: ADVANCES - Medical Distribution · No reproduction or diffusion without written authorization. PACK SIZE: 20 3.5 ml single-dose tubes with built-in applicator. ... ADVANCES. Internal

FIRST LINE APPROACH TO THE TREATMENT OF ANAL FISSURES

SOOTHINGREDUCES PAIN SYMPTOMS

HEALINGIMPROVES TISSUE REPAIR

PROTECTIVELUBRICATES AND PROTECTS

FIRST LINE APPROACH TO THE TREATMENT OF ANAL FISSURES

Obs

idia

n –

Mar

ket a

naly

sis

Page 4: ADVANCES - Medical Distribution · No reproduction or diffusion without written authorization. PACK SIZE: 20 3.5 ml single-dose tubes with built-in applicator. ... ADVANCES. Internal

No

repr

oduc

tion

or d

iffusio

n w

ithou

t writ

ten

auth

oriza

tion

PACK SIZE:20 3.5 ml single-dose tubes with built-in applicator

DOSAGE:Administer 1 application from the single-dose tube, twice a day for at least 20 days

INGREDIENTS:Aqua, dimethicone, glycerin, prunus amygdalus dulcis oil, phenyl trimethicone, borago officinalis seed oil, malva sylvestris extract, panthenol, dextrin, hydrolyzed hibiscus esculentus extract, phenoxyethanol, glyceryl stearate, cetyl alcohol, PEG-75 stearate, acrylates/C10-30 alkyl acrylate crosspolymer, triethanolamine, tocopherol, caprylyl glicol, 1,2-hexanediol, calendula officinalis extract, maltodextrin, glycyrrhiza glabra extract, ceteth-20, steareth-20, ethylhexylglycerin, sodium carboxymethyl beta-glucan, trisodium ethylenediamine disuccinate, tropolone, aspartic acid, sodium chloride, sodium bromide.

MEDICAL

DEVICE

Practical Single Dose Pack:- standard quantity- optimum hygieneReady-to use: specially shaped tube, with built in applicatorPrecise application to specific area

Allows for optimal patient compliance

Nickel free

None Oily: does not mark and washes off easily

in the treatment of anal fissuresADVANCES

Inte

rnal

docu

men

t- In

tend

ed fo

r med

ical p

erso

nnel

only

Obs

idia

n –

Mar

ket a

naly

sis